Picard Medical, Inc. 8-K

What Happened

• On May 29, 2026, Picard Medical, Inc. (PMI) filed a Form 8-K under Regulation FD to furnish a press release that includes a letter from the Company’s Chairman, Richard Fang, addressed to stockholders. The press release is provided as Exhibit 99.1 to the filing.
• The disclosure was furnished (not “filed”) under the Exchange Act, per the company’s statement in the 8-K.

Key Details

• Date of disclosure: May 29, 2026.
• Author and sender: Richard Fang, Chairman of the Board.
• Document furnished: Press release containing the Chairman’s letter (Exhibit 99.1).
• Company note: Information furnished in the 8-K is not subject to the Exchange Act filing liabilities and is not incorporated by reference into other filings.

Why It Matters

• Regulation FD disclosures like this ensure all investors receive the same material communications from company leadership at the same time. For investors, the Chairman’s letter may provide strategic context, updates, or outlook that could be relevant when evaluating the company.
• Because the 8-K furnishes the press release rather than “filing” it, the company is clarifying the limited legal status of this communication under SEC rules; investors should rely on the content of the press release/letter itself for substantive updates.